Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red Mountain Therapeutics is a Danish biotechnology company focused on the discovery and development of next-generation pharmacological treatments for obesity and related metabolic disorders. Founded by industry veterans with extensive experience in metabolic research, the company aims to address the global obesity epidemic through innovative peptide-based therapies. Their research focuses on multi-agonist peptides that target key metabolic pathways to achieve superior weight loss and metabolic improvements compared to existing standards of care. Red Mountain leverages advanced peptide engineering to optimize the efficacy, safety, and tolerability profiles of its therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red Mountain.